Treatment options in patients with rheumatoid arthritis failing initial TNF inhibitor therapy: a critical review

Conventional disease-modifying antirheumatic drugs such as methotrexate are the mainstay of treatment for rheumatoid arthritis. More recently, biologic agents such as etanercept, infliximab and adalimumab, which act by inhibiting tumour necrosis factor (TNF), have become available. TNF inhibitors ha...

Full description

Saved in:
Bibliographic Details
Main Authors: Rubbert-Roth, Andrea, Finckh, Axel
Format: Artigo
Language:Inglês
Published: BioMed Central 2009
Subjects:
Review
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2669237/
https://ncbi.nlm.nih.gov/pubmed/19368701
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/ar2666
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items